Cargando…
Androgen deprivation therapy prevents bladder cancer recurrence
Although accumulating preclinical evidence indicates the involvement of androgen receptor signals in bladder cancer (BC) development, its clinical relevance remains unclear. We aimed to evaluate the predictive role of androgen deprivation therapy (ADT) in BC recurrence in prostate cancer (PC) patien...
Autores principales: | Izumi, Koji, Taguri, Masataka, Miyamoto, Hiroshi, Hara, Yoshinori, Kishida, Takeshi, Chiba, Kimio, Murai, Tetsuo, Hirai, Kotaro, Suzuki, Kotaro, Fujinami, Kiyoshi, Ueki, Teiichiro, Udagawa, Koichi, Kitami, Kazuo, Moriyama, Masatoshi, Miyoshi, Yasuhide, Tsuchiya, Futoshi, Ikeda, Ichiro, Kobayashi, Kazuki, Sato, Maho, Morita, Satoshi, Noguchi, Kazumi, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350350/ https://www.ncbi.nlm.nih.gov/pubmed/25557268 |
Ejemplares similares
-
Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015) -
Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
por: Izumi, Koji, et al.
Publicado: (2016) -
Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel
por: Kawahara, Takashi, et al.
Publicado: (2012) -
Clear cell adenocarcinoma of the prostatic urethra: A case report
por: Sugimura, Rumiko, et al.
Publicado: (2018) -
Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
por: Uemura, Koichi, et al.
Publicado: (2016)